Single intravenous preoperative administration of the oncolytic virus Pexa-Vec to prime anti-tumor immunity.

3092Background: Oncolytic viruses (OV) constitute a promising modality of cancer therapy. Intra-tumoral administration has yielded encouraging clinical results, but restricted the use of OV to tumo...